Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Frye

Showing results (21-30 of 57) with videos related to

Pageof 6
Sort By:
Psychoneuroendocrinology|February 17, 2020
Alterations in levels of 8-Oxo-2'-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depressionDeniz Ceylan, Selda Yılmaz, Gamze Tuna, et al.
International Journal of Bipolar Disorders|December 17, 2019
Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar NetworkFrancis Bennett, Sophie Hodgetts, Andrew Close, et al.
The American Journal of Psychiatry|July 2, 2003
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen, Terence A Ketter, Carlos A Zarate, et al.
Plos One|September 22, 2018
Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohortsJoey Ward, Nicholas Graham, Rona J Strawbridge, et al.
Journal of Affective Disorders|December 8, 2022
Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depressionAdrienne Lapidos, Daniela Lopez-Vives, Cortney E Sera, et al.
Research Square|February 6, 2026
The Anxious Bipolar Phenotype: Clinical Complexity and Treatment ResistanceBalwinder Singh, Ada Man-Choi Ho, Brandon Coombes, et al.
Molecular Psychiatry|August 6, 2020
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment responseMing-Fen Ho, Cheng Zhang, Lingxin Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Cellular and functional dissection of the octopaminergic system in the <i>Drosophila</i> brainLesly M Palacios Castillo, Valentina Fajner, Ezgi Yalbir, et al.
Journal of Medical Internet Research|December 29, 2023
Digital Phenotyping for Mood Disorders: Methodology-Oriented Pilot Feasibility StudyScott Breitinger, Manuel Gardea-Resendez, Carsten Langholm, et al.
Molecular Metabolism|June 25, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolismMing-Fen Ho, Cheng Zhang, Irene Moon, et al.
Pageof 6

Showing results (21-30 of 57) with videos related to

Sort By:
Pageof 6
Psychoneuroendocrinology|February 17, 2020
Alterations in levels of 8-Oxo-2'-deoxyguanosine and 8-Oxoguanine DNA glycosylase 1 during a current episode and after remission in unipolar and bipolar depressionDeniz Ceylan, Selda Yılmaz, Gamze Tuna, et al.
International Journal of Bipolar Disorders|December 17, 2019
Predictors of psychosocial outcome of bipolar disorder: data from the Stanley Foundation Bipolar NetworkFrancis Bennett, Sophie Hodgetts, Andrew Close, et al.
The American Journal of Psychiatry|July 2, 2003
Olanzapine versus divalproex sodium for the treatment of acute mania and maintenance of remission: a 47-week studyMauricio Tohen, Terence A Ketter, Carlos A Zarate, et al.
Plos One|September 22, 2018
Polygenic risk scores for major depressive disorder and neuroticism as predictors of antidepressant response: Meta-analysis of three treatment cohortsJoey Ward, Nicholas Graham, Rona J Strawbridge, et al.
Journal of Affective Disorders|December 8, 2022
Patients' recovery and non-recovery narratives after intravenous ketamine for treatment-resistant depressionAdrienne Lapidos, Daniela Lopez-Vives, Cortney E Sera, et al.
Research Square|February 6, 2026
The Anxious Bipolar Phenotype: Clinical Complexity and Treatment ResistanceBalwinder Singh, Ada Man-Choi Ho, Brandon Coombes, et al.
Molecular Psychiatry|August 6, 2020
TSPAN5 influences serotonin and kynurenine: pharmacogenomic mechanisms related to alcohol use disorder and acamprosate treatment responseMing-Fen Ho, Cheng Zhang, Lingxin Zhang, et al.
Biorxiv : the Preprint Server for Biology|February 23, 2026
Cellular and functional dissection of the octopaminergic system in the <i>Drosophila</i> brainLesly M Palacios Castillo, Valentina Fajner, Ezgi Yalbir, et al.
Journal of Medical Internet Research|December 29, 2023
Digital Phenotyping for Mood Disorders: Methodology-Oriented Pilot Feasibility StudyScott Breitinger, Manuel Gardea-Resendez, Carsten Langholm, et al.
Molecular Metabolism|June 25, 2022
Genome-wide association study for circulating FGF21 in patients with alcohol use disorder: Molecular links between the SNHG16 locus and catecholamine metabolismMing-Fen Ho, Cheng Zhang, Irene Moon, et al.
Pageof 6